Hepion Pharmaceuticals, Inc. (CTRVP)
OTC: CTRVP · CIK 0001583771 · United States
Every official Hepion Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CTRVP filings
Hepion Pharmaceuticals, Inc. documents
- Hepion Pharmaceuticals, Inc. 10-K 2026CTRVP 10-K 2026: annual report for fiscal 2026
- Hepion Pharmaceuticals, Inc. 10-K 2025CTRVP 10-K 2025: annual report for fiscal 2025
- Hepion Pharmaceuticals, Inc. 10-K 2024CTRVP 10-K 2024: annual report for fiscal 2024
- Hepion Pharmaceuticals, Inc. 10-K 2023CTRVP 10-K 2023: annual report for fiscal 2023
- Hepion Pharmaceuticals, Inc. 10-K 2022CTRVP 10-K 2022: annual report for fiscal 2022
- Hepion Pharmaceuticals, Inc. 10-Q 2026CTRVP 10-Q 2026: quarterly report for fiscal 2026
- Hepion Pharmaceuticals, Inc. 10-Q 2025CTRVP 10-Q 2025: quarterly report for fiscal 2025
- Hepion Pharmaceuticals, Inc. 10-Q 2024CTRVP 10-Q 2024: quarterly report for fiscal 2024
- Hepion Pharmaceuticals, Inc. 10-Q 2023CTRVP 10-Q 2023: quarterly report for fiscal 2023
- Hepion Pharmaceuticals, Inc. 10-Q 2022CTRVP 10-Q 2022: quarterly report for fiscal 2022
- Hepion Pharmaceuticals, Inc. 8-K 2026CTRVP 8-K 2026: current report for fiscal 2026
- Hepion Pharmaceuticals, Inc. 8-K 2025CTRVP 8-K 2025: current report for fiscal 2025
- Hepion Pharmaceuticals, Inc. 8-K 2024CTRVP 8-K 2024: current report for fiscal 2024
- Hepion Pharmaceuticals, Inc. 8-K 2023CTRVP 8-K 2023: current report for fiscal 2023
- Hepion Pharmaceuticals, Inc. 8-K 2022CTRVP 8-K 2022: current report for fiscal 2022
- Hepion Pharmaceuticals, Inc. DEF 14A 2026CTRVP DEF 14A 2026: proxy statement for fiscal 2026
- Hepion Pharmaceuticals, Inc. DEF 14A 2025CTRVP DEF 14A 2025: proxy statement for fiscal 2025
- Hepion Pharmaceuticals, Inc. DEF 14A 2024CTRVP DEF 14A 2024: proxy statement for fiscal 2024
- Hepion Pharmaceuticals, Inc. DEF 14A 2023CTRVP DEF 14A 2023: proxy statement for fiscal 2023
- Hepion Pharmaceuticals, Inc. DEF 14A 2022CTRVP DEF 14A 2022: proxy statement for fiscal 2022
- Hepion Pharmaceuticals, Inc. Form 4 2026CTRVP Form 4 2026: insider trading filing for fiscal 2026
- Hepion Pharmaceuticals, Inc. Form 4 2025CTRVP Form 4 2025: insider trading filing for fiscal 2025
- Hepion Pharmaceuticals, Inc. Form 4 2024CTRVP Form 4 2024: insider trading filing for fiscal 2024
- Hepion Pharmaceuticals, Inc. Form 4 2023CTRVP Form 4 2023: insider trading filing for fiscal 2023
- Hepion Pharmaceuticals, Inc. Form 4 2022CTRVP Form 4 2022: insider trading filing for fiscal 2022
- Hepion Pharmaceuticals, Inc. S-1 2026CTRVP S-1 2026: registration statement for fiscal 2026
- Hepion Pharmaceuticals, Inc. S-1 2025CTRVP S-1 2025: registration statement for fiscal 2025
- Hepion Pharmaceuticals, Inc. S-1 2024CTRVP S-1 2024: registration statement for fiscal 2024
- Hepion Pharmaceuticals, Inc. S-1 2023CTRVP S-1 2023: registration statement for fiscal 2023
- Hepion Pharmaceuticals, Inc. S-1 2022CTRVP S-1 2022: registration statement for fiscal 2022
- Hepion Pharmaceuticals, Inc. 13F 2026CTRVP 13F 2026: institutional holdings for fiscal 2026
- Hepion Pharmaceuticals, Inc. 13F 2025CTRVP 13F 2025: institutional holdings for fiscal 2025
- Hepion Pharmaceuticals, Inc. 13F 2024CTRVP 13F 2024: institutional holdings for fiscal 2024
- Hepion Pharmaceuticals, Inc. 13F 2023CTRVP 13F 2023: institutional holdings for fiscal 2023
- Hepion Pharmaceuticals, Inc. 13F 2022CTRVP 13F 2022: institutional holdings for fiscal 2022
More companies